How to switch GLP-1 programs without losing prescription continuity

TLDR. A clean switch between GLP-1 telehealth programs takes 21 to 30 days and follows a specific sequence: enroll with the new program first, confirm prescription approval before canceling the old one, schedule the new shipment to arrive before the old supply runs out, and never let the medication gap exceed 14 days. Cancel timing matters: cancel too early and the new program may not have your prescription yet, cancel too late and you pay for an overlap month. Most patients lose money or doses by sequencing this wrong.

Patients switch GLP-1 telehealth programs for the same reasons people switch any subscription: price, service, medication availability, or a billing dispute. The switch itself is mechanically routine. The way most patients break it is not by choosing the wrong destination program but by mis-sequencing the cancellation against the enrollment.

The bad outcomes are predictable. Cancel the old program before the new prescription is approved and you have no medication for two to three weeks. Wait too long to cancel and you pay for an overlap month. Let the gap exceed 21 days at maintenance dose and your new prescriber may restart you from the lowest titration step, costing you three months of progress.

This post gives the explicit sequence that avoids each of those failures.

The seven-step sequence

The complete sequence for switching from program A to program B without losing prescription continuity:

1. Inventory your current supply. Open your refrigerator. Count the pens, vials, or syringes. Write down the exact date your current supply runs out at your current dose. This is your hard deadline.
2. Read program B's onboarding timeline. Most major programs publish how long their intake takes from signup to first shipment. Mochi, Hims, and Ro typically run 7 to 14 days from signup to first medication arrival. Slower programs (Calibrate, Found, WeightWatchers Clinic) can run 14 to 21 days.
3. Sign up with program B and complete the intake. Pay the first month, complete the medical assessment, upload your prior dosing history, and request a transfer of the prescription if program B supports it. Be explicit about your current dose: the new prescriber should write at the same dose, not restart from titration.
4. Confirm prescription approval from program B in writing. Do not move to step 5 until you have an email or in-portal message confirming the prescription has been approved and submitted to a pharmacy. "Pending medical review" is not approval.
5. Schedule program B's first shipment. Time the first shipment to arrive 5 to 7 days before your current supply runs out. This buffer absorbs any shipping delay, weather event, or pharmacy backorder.
6. Cancel program A. Cancel after step 4 confirms approval, ideally 5 to 10 days before program A's next auto-renewal billing date. Use self-serve cancel if available; phone-cancel programs (WeightWatchers Clinic) require business-hours timing.
7. Document the cancellation. Screenshot the cancellation confirmation page or save the confirmation email. If program A bills again after the documented cancellation date, this is the evidence for a chargeback dispute.

The whole sequence runs 14 to 30 days. Patients who try to compress it into a week routinely create gaps.

Why the prescription transfer matters

The prescription itself does not move between programs. Program A's prescriber wrote the script and sent it to program A's partner pharmacy. Program B's prescriber writes a new prescription and sends it to program B's partner pharmacy. The patient effectively has two prescriptions from two prescribers at two pharmacies for the same medication.

The "transfer" is really a request for program B's prescriber to write at the same dose the patient was on with program A, rather than restart titration from 0.25 mg. The mechanism varies by program. Most modern programs (Mochi, Hims, Ro, Noom Med) ask new patients to upload prior dosing history during intake. The new prescriber reviews and writes accordingly.

The patient's job: have proof of your current dose. A photo of the most recent pen label, a screenshot of your prior portal showing dose history, or a recent receipt from program A's pharmacy. Without proof, some prescribers default to restarting titration as the safer clinical choice. With proof, most prescribers write at the current dose.

The 14-day rule

The Wegovy and Zepbound prescribing information addresses missed doses: if a dose is missed and the next scheduled dose is more than two days away, take the missed dose. If less than two days away, skip the missed dose and resume at the next scheduled dose.

For longer gaps (a week or more without dosing), clinical practice has settled around a 14-day soft threshold and a 21-day hard threshold. Up to 14 days off, most prescribers resume at the prior maintenance dose. Between 14 and 21 days, some prescribers step back one dose level. Past 21 days, most prescribers restart titration from a lower step (often the dose that was last tolerated without GI breakthrough).

The clinical reasoning: GLP-1 tolerance is partially driven by ongoing receptor exposure. A longer gap allows GI side effects to re-emerge at the same dose. The titration restart is a tolerance-protective measure, not an efficacy measure.

For the patient switching programs: plan the new shipment to arrive within 14 days of the last dose from the old program. The 5- to 7-day buffer in step 5 above provides margin. Patients who let the gap exceed 21 days often end up restarting from 1.0 mg or 0.5 mg and losing two to three months of progress.

The auto-renewal trap

Every major program in the chart auto-renews. The cancellation needs to happen on the right side of the next billing date or the patient pays for a month they will not use.

The standard pattern: the program bills monthly on the same date the patient signed up. A signup on March 5 means billing on April 5, May 5, June 5, and so on. Cancellation made on April 4 prevents the April 5 charge. Cancellation made on April 6 has already incurred the April charge.

Programs vary in their cancellation deadline:

• Mochi, Hims, Noom Med, PlushCare: Self-serve cancel up to the day of billing. Cancel by 11:59 PM the day before the renewal date.
• Ro: Self-serve cancel with a 24- to 48-hour processing window. Cancel 48 hours before the renewal date to be safe.
• Calibrate: Cancel during the first 14 days of any month to avoid that month's charge if on monthly billing; non-refundable if on the 3-month prepay.
• Found: CORE prepay is non-refundable. Kickstart 3-month plan can be canceled but the upfront amount is not refunded.
• WeightWatchers Clinic: Phone cancel only, during business hours. The 12-month commitment is not voidable inside the window.

Patients on prepay plans have a structural problem: the prepay is what it is. Switching programs mid-prepay loses the unused portion. The financially clean switch happens at the end of a prepay window, not in the middle.

The dose-continuity question for the new prescriber

When intake forms ask about prior dosing, give the most specific answer possible:

• Last dose taken (date and dose level)
• Duration at current dose
• Total duration on the medication
• GI side effects encountered at higher dose attempts
• Any dose reductions and the reason

The new prescriber will use this to decide whether to write at the same dose or step back. The patient who provides specific dose history gets specific care. The patient who writes "I was on Wegovy for a few months" gets a default titration restart.

What to ask the new program before signing up

Five questions worth answering before paying the first month:

1. "How do you handle dose continuity for switch patients?" Acceptable answers: "We write at your current dose with proof of prior dosing history." Unacceptable: "All new patients start at 0.25 mg."
2. "What is the time from intake to first medication shipment?" 7 to 14 days is normal. 21+ days is a flag if you are switching with limited supply.
3. "Which pharmacy fills your prescriptions?" Branded GLP-1 patients want this to be NovoCare, LillyDirect, or a major retail chain. Compounded patients want a 503A pharmacy with disclosed enforcement history.
4. "What happens if my insurance prior authorization is denied?" Programs should have a documented appeals process. "We can't help with insurance" is a flag.
5. "How do I cancel?" Self-serve online cancel is the right answer. Phone-only or email-request cancel is a sign of retention friction.

The financial overlap math

A clean switch costs one month of overlap in the worst case (rare) and zero months of overlap in the typical case. The pattern:

• Best case: Sign up with program B on day 1. Complete intake by day 7. Prescription approved by day 10. First shipment arrives day 14. Cancel program A by day 14. Last shipment from program A arrives day 28. Total cost: one month with each program, no overlap.
• Worst case: Sign up with program B on day 1. Intake delayed. Prescription approved day 18. First shipment arrives day 25. Patient continued program A through the uncertainty. Cancel program A on day 22 (after billing). Total cost: two months of program A plus one month of program B for the same supply.

The financial cost of getting it wrong is one extra membership ($75 to $300) plus possibly one extra medication payment ($100 to $500). The clinical cost of getting it wrong is a 21-day gap that triggers a titration restart and loses two to three months of progress.

The clinical cost is larger than the financial cost. Err toward overlap rather than gap if the timing gets tight.

When switching does not work

Three scenarios where the switch creates more problems than it solves:

• Mid-prepay on a non-refundable program. Found CORE ($594 for 6 months) and Calibrate ($597 for 3 months) lock the upfront amount. Switching mid-window forfeits the unused portion. Wait for the prepay window to end.
• Inside a multi-month commitment. WeightWatchers Clinic's 12-month commitment is not voidable. Either pay it out or pay the full term in lump.
• Mid-titration with one program. A patient who has been on Wegovy 0.5 mg for two weeks and wants to switch will have to restart titration with the new prescriber anyway. The switch costs nothing in dose continuity. Switch freely if the program is the problem.

The compounded-to-branded switch (a special case)

A patient switching from compounded semaglutide to branded Wegovy (or compounded tirzepatide to branded Zepbound) has a different sequencing problem. The compounded dose may not map cleanly to a branded titration step.

Most prescribers handle the switch by translating the compounded dose to the nearest branded dose. A patient on 0.5 mg per week of compounded semaglutide moves to Wegovy 0.5 mg. A patient on 1.0 mg of compounded moves to Wegovy 1.0 mg. Higher compounded doses (some 503A pharmacies titrate to 2.4 mg or beyond) map to the highest branded dose available, which for Wegovy is 2.4 mg.

The bigger issue with this switch is insurance. Compounded was usually cash-pay. Branded usually goes through insurance with prior authorization, which takes 1 to 4 weeks. Patients should start the insurance PA process before exhausting their compounded supply. See our compounded-to-brand switch guide for the full mechanics.

Frequently asked questions

How long can I go without a GLP-1 dose before I lose progress?

Up to 14 days off the medication at maintenance dose, most patients resume at the same dose without issue. Between 14 and 21 days, some prescribers step back one dose level to manage tolerance. Past 21 days, most prescribers restart titration from a lower step, which can cost two to three months of dose progression. Plan switches to keep gaps under 14 days.

Will my new program honor my current dose?

If you can document your current dose (pen label photo, prior portal screenshot, pharmacy receipt) and the gap between programs is under 14 days, most programs will continue you at the same dose. Without documentation or with a longer gap, the new prescriber may default to a titration restart as the safer clinical choice.

What if I cancel my old program and the new program denies my prescription?

This is the worst-case sequencing error. The fix: re-enroll with the original program or a third program, paying the membership fee again. Some programs can fast-track a returning patient. The cost is one month of membership plus the gap in medication, which may force a titration restart at the next prescriber.

Can I run two GLP-1 programs at the same time?

Briefly, yes. A two- to four-week overlap during a clean switch is sensible insurance against gaps. Continuously running two programs is wasteful: only one shipment becomes the active supply, the other sits in the fridge until expiration. Most patients in the chart who have done this end up canceling one program after two months.

Does my insurance carry over to the new program?

Insurance attaches to the patient and the pharmacy, not to the telehealth program. A patient with Wegovy covered under their commercial plan can take that coverage to any program that uses an in-network pharmacy. The new program will need to submit a new prior authorization request to the insurance plan, which usually takes 1 to 4 weeks. Most plans approve a re-PA quickly when the prior approval is on file.

What if the new program uses a different pharmacy?

This is the most common cause of insurance friction during a switch. Program A may use NovoCare; program B may use a partner specialty pharmacy. The patient's insurance may cover Wegovy through NovoCare but not through the specialty pharmacy, or vice versa. Ask program B which pharmacy fills the prescription before signing up, and verify with the insurance plan that the pharmacy is in-network.

Should I switch if I just paid the next month?

Generally no. Use the month you paid for. Sign up with the new program in the second-to-last week of the paid month, complete the intake during the last week, and time the first new-program shipment to arrive at or just after the paid month ends. This sequencing avoids paying for an overlap.

How do I dispute a charge from the old program after I canceled?

Document the cancellation: screenshot the confirmation page, save the confirmation email. If the program bills after the documented cancellation date, contact the program first for a refund. If the program refuses, file a chargeback with the credit card company. Mandatory arbitration clauses in program terms of service do not block credit card chargebacks for billing disputes.

Citations

• FDA. Wegovy (semaglutide) prescribing information, missed dose guidance. accessdata.fda.gov/drugsatfda_docs/label/2024/215256s011lbl.pdf
• FDA. Zepbound (tirzepatide) prescribing information, dose modification guidance. accessdata.fda.gov/drugsatfda_docs/label/2024/217806s006lbl.pdf
• American Diabetes Association. Standards of Care in Diabetes 2026, Pharmacologic Approaches to Glycemic Treatment. diabetesjournals.org/care/issue/49/Supplement_1
• Obesity Medicine Association. Clinical Practice Statement on Obesity Pharmacotherapy 2024. obesitymedicine.org/about/clinical-practice-statement/
• Consumer Financial Protection Bureau. Subscription cancellation rights and chargeback procedures. consumerfinance.gov/ask-cfpb/what-is-a-credit-card-chargeback-en-1265/